Search

Anthony R. Shumate

Examiner (ID: 8550, Phone: (571)270-5546 , Office: P/1773 )

Most Active Art Unit
1776
Art Unit(s)
1776, 1775, 1772, 1773, 1797
Total Applications
1073
Issued Applications
791
Pending Applications
70
Abandoned Applications
234

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5177390 [patent_doc_number] => 20070178450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Method and apparatus for determining level of microorganisms using bacteriophage' [patent_app_type] => utility [patent_app_number] => 11/698673 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8286 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178450.pdf [firstpage_image] =>[orig_patent_app_number] => 11698673 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/698673
Method and apparatus for determining level of microorganisms using bacteriophage Jan 24, 2007 Abandoned
Array ( [id] => 5219776 [patent_doc_number] => 20070161087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'GLP-1 FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/622073 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27120 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161087.pdf [firstpage_image] =>[orig_patent_app_number] => 11622073 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/622073
GLP-1 FUSION PROTEINS Jan 10, 2007 Abandoned
Array ( [id] => 5188061 [patent_doc_number] => 20070166369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Photodynamic cosmetic procedure and healing method' [patent_app_type] => utility [patent_app_number] => 11/650207 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4592 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166369.pdf [firstpage_image] =>[orig_patent_app_number] => 11650207 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650207
Photodynamic cosmetic procedure and healing method Jan 4, 2007 Issued
Array ( [id] => 5028416 [patent_doc_number] => 20070269863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Process for the production of preformed conjugates of albumin and a therapeutic agent' [patent_app_type] => utility [patent_app_number] => 11/645297 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24576 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269863.pdf [firstpage_image] =>[orig_patent_app_number] => 11645297 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/645297
Process for the production of preformed conjugates of albumin and a therapeutic agent Dec 21, 2006 Abandoned
Array ( [id] => 5225775 [patent_doc_number] => 20070255042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Production of chiral materials using crystallization inhibitors' [patent_app_type] => utility [patent_app_number] => 11/641344 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17707 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20070255042.pdf [firstpage_image] =>[orig_patent_app_number] => 11641344 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/641344
Production of chiral materials using crystallization inhibitors Dec 18, 2006 Abandoned
Array ( [id] => 4990994 [patent_doc_number] => 20070157335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Altering Protein Functional Properties Through Terminal Fusions' [patent_app_type] => utility [patent_app_number] => 11/609359 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9590 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20070157335.pdf [firstpage_image] =>[orig_patent_app_number] => 11609359 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/609359
Altering Protein Functional Properties Through Terminal Fusions Dec 11, 2006 Abandoned
Array ( [id] => 5458802 [patent_doc_number] => 20090258954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'PROTECTIVE HYDROCOLLOID FOR ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 12/095927 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16055 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258954.pdf [firstpage_image] =>[orig_patent_app_number] => 12095927 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095927
PROTECTIVE HYDROCOLLOID FOR ACTIVE INGREDIENTS Dec 7, 2006 Abandoned
Array ( [id] => 4832953 [patent_doc_number] => 20080131500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR RAPID INACTIVATION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/566595 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12873 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131500.pdf [firstpage_image] =>[orig_patent_app_number] => 11566595 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/566595
METHODS AND COMPOSITIONS FOR RAPID INACTIVATION OF PROTEINS Dec 3, 2006 Abandoned
Array ( [id] => 7762382 [patent_doc_number] => 08114843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Photoreactive regulator of protein function and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/601591 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 44 [patent_no_of_words] => 52485 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114843.pdf [firstpage_image] =>[orig_patent_app_number] => 11601591 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/601591
Photoreactive regulator of protein function and methods of use thereof Nov 16, 2006 Issued
Array ( [id] => 5107657 [patent_doc_number] => 20070066535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Novel haptotactic peptides' [patent_app_type] => utility [patent_app_number] => 11/601024 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9036 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066535.pdf [firstpage_image] =>[orig_patent_app_number] => 11601024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/601024
Haptotactic peptides Nov 16, 2006 Issued
Array ( [id] => 7996775 [patent_doc_number] => 08080235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Protein kinase A reporters useful in high throughput assays' [patent_app_type] => utility [patent_app_number] => 12/091858 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 25 [patent_no_of_words] => 8457 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080235.pdf [firstpage_image] =>[orig_patent_app_number] => 12091858 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/091858
Protein kinase A reporters useful in high throughput assays Oct 25, 2006 Issued
Array ( [id] => 820599 [patent_doc_number] => 07407932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Methods for glucagon suppression using modified exendins' [patent_app_type] => utility [patent_app_number] => 11/584114 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 19150 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407932.pdf [firstpage_image] =>[orig_patent_app_number] => 11584114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/584114
Methods for glucagon suppression using modified exendins Oct 18, 2006 Issued
Array ( [id] => 5367082 [patent_doc_number] => 20090304641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Methods and Compositions for Regulating Gene Expression' [patent_app_type] => utility [patent_app_number] => 12/083743 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16116 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304641.pdf [firstpage_image] =>[orig_patent_app_number] => 12083743 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083743
Methods and Compositions for Regulating Gene Expression Oct 16, 2006 Abandoned
Array ( [id] => 5252773 [patent_doc_number] => 20070134229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Non-native constitutively active osteopontin' [patent_app_type] => utility [patent_app_number] => 11/546087 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17120 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134229.pdf [firstpage_image] =>[orig_patent_app_number] => 11546087 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/546087
Non-native constitutively active osteopontin Oct 9, 2006 Abandoned
Array ( [id] => 6585387 [patent_doc_number] => 20100047861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'PROCESS FOR PRODUCING USEFUL SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 12/067797 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10810 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047861.pdf [firstpage_image] =>[orig_patent_app_number] => 12067797 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067797
PROCESS FOR PRODUCING USEFUL SUBSTANCE Sep 27, 2006 Abandoned
Array ( [id] => 5095570 [patent_doc_number] => 20070117179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'IN VITRO PROTEIN SYNTHESIS SYSTEMS FOR MEMBRANE PROTEINS THAT INCLUDE ADOLIPOPROTEINS AND PHOSPHOLIPID-ADOLIPOPROTEIN PARTICLES' [patent_app_type] => utility [patent_app_number] => 11/535960 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117179.pdf [firstpage_image] =>[orig_patent_app_number] => 11535960 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/535960
IN VITRO PROTEIN SYNTHESIS SYSTEMS FOR MEMBRANE PROTEINS THAT INCLUDE ADOLIPOPROTEINS AND PHOSPHOLIPID-ADOLIPOPROTEIN PARTICLES Sep 26, 2006 Abandoned
Array ( [id] => 5242233 [patent_doc_number] => 20070020728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Muteins of apolipoprotein D' [patent_app_type] => utility [patent_app_number] => 11/526033 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13817 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020728.pdf [firstpage_image] =>[orig_patent_app_number] => 11526033 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/526033
Muteins of apolipoprotein D Sep 24, 2006 Abandoned
Array ( [id] => 5243097 [patent_doc_number] => 20070021592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'NPC1L1 (NPC3) and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/523512 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24500 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021592.pdf [firstpage_image] =>[orig_patent_app_number] => 11523512 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/523512
NPC1L1 (NPC3) and methods of use thereof Sep 18, 2006 Abandoned
Array ( [id] => 83629 [patent_doc_number] => 07741274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Casein derived peptides and uses thereof in therapy' [patent_app_type] => utility [patent_app_number] => 11/518400 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 27833 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741274.pdf [firstpage_image] =>[orig_patent_app_number] => 11518400 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/518400
Casein derived peptides and uses thereof in therapy Sep 7, 2006 Issued
Array ( [id] => 10161438 [patent_doc_number] => 09192648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Method of treating myasthenia gravis' [patent_app_type] => utility [patent_app_number] => 11/991690 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 6214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11991690 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/991690
Method of treating myasthenia gravis Sep 4, 2006 Issued
Menu